骨痹清方治疗膝骨关节炎并滑膜炎的疗效观察及实验研究
|
摘要
本研究以祖国医学理论为指导,从理论探讨、临床疗效观察及实验研究三方面对中药骨痹清方治疗膝骨关节炎(KOA)并滑膜炎的机制进行了探索。提出KOA并滑膜炎的主要病机是湿热痰瘀胶结,蕴化为毒,痹阻气血经络,损伤筋骨关节,日久致痹。治以清热解毒利湿为主,兼以活血、扶正,选用根据导师多年临床经验拟定的“骨痹清方”,从宏观临床疗效和微观细胞水平两方面探讨其治疗机理。
临床将98例符合KOA并滑膜炎患者随机分为观察组(骨痹清方组)和对照组(新癀片组),以临床总疗效、中医证候、WOMAC问卷以及临床症状体征总体评分和单一症状体征评分等为观察指标,并根据服药不同时程,分阶段评价其临床疗效及安全性。结果显示骨痹清方能明显改善KOA并滑膜炎患者中医证候、生理功能和临床症状体征,疗效优于新癀片组,观察期内疗效与疗程成正相关,且无明显的毒副反应,安全性高。
实验研究应用MTT法、流式细胞仪和RT-PCR等方法观测不同浓度的骨痹清方、新癀片药液对体外培养KOA并滑膜炎患者滑膜成纤维细胞(OA-FLS)增殖分化的影响。结果骨痹清方和新癀片均能抑制OA-FLS增殖,两种药物生理剂量下可抑制OA-FLS有丝分裂,缩短S期,延长G1期,高浓度骨痹清方能诱导OA-FLS细胞凋亡;骨痹清方能明显抑制OA-FLS细胞c-fos和COX-2 mRNA表达。
结论:以骨痹清方为代表的清热解毒利湿方药能直接从转录水平抑制OA-FLS细胞的增殖分化,通过多途径、多环节、多靶点发挥整体调节作用,逆转湿热郁毒痹阻的根本病机,从而抑制滑膜炎症,减轻软骨破坏,从根本上治疗膝骨关节炎并滑膜炎。
In this study,we take the medical theory of Traditional Chinese medicine (TCM) as a guide and investigate the mechanism of Gubiqing-Recipe in knee osteoarthritis (KOA) complicated with gonarthromeningitis from the theoretical study, clinical observations and experimental study.
KOA is induced by damp-heat toxin for the Arthralgia Syndrome. Arthralgia Syndrome is caused by damp-heat, phlegm and blood stasis which are coagulated and accumulated into toxin, blockage of qi-blood circulation and damages of bones joints. We advocate using clearing away the heat-evil, expelling superficial evils, removing dampness as the chief treatment, and activating blood circulation to dissipate blood stasis, strengthening the body resistance meanwhile. The patients were treated with Gubiqing-Recipe that on establishment of tutor years of clinical experience of KOA. To explore possible action mechanism of KOA treatment of clinical efficacy from the macro and the cellular level from micro. 98 cases with KOA complicated with gonarthro- meningitis were randomly divided into test group (Gubiqing-Recipe) and control group (Xinhuang Tablet). Two groups take the indicators for observation such as total curative effect, TCM syndrome, WOMAC questionnaire, the clinical symptoms and signs of a single overall score and score symptoms and signs. Clinical efficacy and safety in accordance with time-phased medication was evaluated. The results show that Gubiqing-Recipe can significantly improve the KOA complicated with gonarthro- meningitis patients’TCM systemic symptoms, physiological functions,symptoms and signs. The Gubiqing-Recipe group curative effect surpasses the Xinhuang Tablet group. In observation period curative effect superiority along with treatment time expands. Gubiqing-Recipe has not obvious poisonous side reaction and has highly the security. We raise the OA-FLS cells in vitro of KOA complicated with gonarthromeningitis patients’synovial membrane, and observe the influence of different concentrations Gubiqing-Recipe and Xinhuang Tablet on cell growth and proliferation by MTT, flow cytometry and RT-PCR methods. The results show that Gubiqing-Recipe and Xinhuang Tablet can suppress the OA-FLS multiplication. Two medicines may suppress the OA-FLS mitosis in the physiological dosage, reduces the S time, lengthens the G1 time and the highly concentrated Gubiqing-Recipe can induce the OA-FLS cell apoptosis. Gubiqing-Recipe can obviously inhibited c-fos and COX-2 mRNA expressions of OA-FLS. Conclusion: Gubiqing-Recipe of clearing heat, detoxication, dispelling damp can inhibit OA-FLS cells’proliferation and differentiation directly from the transcription level. Gubiqing-Recipe display conformity control action through multi-ways, multi-links and multi-target. Gubiqing-Recipe can reverse basic pathogenesis that blockage of hot, damp, stasis and poisonous, restrain inflammation of synovium , decrease cartilage destruction, yield a radical cure of KOA complicated with gonarthromeningitis.
临床将98例符合KOA并滑膜炎患者随机分为观察组(骨痹清方组)和对照组(新癀片组),以临床总疗效、中医证候、WOMAC问卷以及临床症状体征总体评分和单一症状体征评分等为观察指标,并根据服药不同时程,分阶段评价其临床疗效及安全性。结果显示骨痹清方能明显改善KOA并滑膜炎患者中医证候、生理功能和临床症状体征,疗效优于新癀片组,观察期内疗效与疗程成正相关,且无明显的毒副反应,安全性高。
实验研究应用MTT法、流式细胞仪和RT-PCR等方法观测不同浓度的骨痹清方、新癀片药液对体外培养KOA并滑膜炎患者滑膜成纤维细胞(OA-FLS)增殖分化的影响。结果骨痹清方和新癀片均能抑制OA-FLS增殖,两种药物生理剂量下可抑制OA-FLS有丝分裂,缩短S期,延长G1期,高浓度骨痹清方能诱导OA-FLS细胞凋亡;骨痹清方能明显抑制OA-FLS细胞c-fos和COX-2 mRNA表达。
结论:以骨痹清方为代表的清热解毒利湿方药能直接从转录水平抑制OA-FLS细胞的增殖分化,通过多途径、多环节、多靶点发挥整体调节作用,逆转湿热郁毒痹阻的根本病机,从而抑制滑膜炎症,减轻软骨破坏,从根本上治疗膝骨关节炎并滑膜炎。
In this study,we take the medical theory of Traditional Chinese medicine (TCM) as a guide and investigate the mechanism of Gubiqing-Recipe in knee osteoarthritis (KOA) complicated with gonarthromeningitis from the theoretical study, clinical observations and experimental study.
KOA is induced by damp-heat toxin for the Arthralgia Syndrome. Arthralgia Syndrome is caused by damp-heat, phlegm and blood stasis which are coagulated and accumulated into toxin, blockage of qi-blood circulation and damages of bones joints. We advocate using clearing away the heat-evil, expelling superficial evils, removing dampness as the chief treatment, and activating blood circulation to dissipate blood stasis, strengthening the body resistance meanwhile. The patients were treated with Gubiqing-Recipe that on establishment of tutor years of clinical experience of KOA. To explore possible action mechanism of KOA treatment of clinical efficacy from the macro and the cellular level from micro. 98 cases with KOA complicated with gonarthro- meningitis were randomly divided into test group (Gubiqing-Recipe) and control group (Xinhuang Tablet). Two groups take the indicators for observation such as total curative effect, TCM syndrome, WOMAC questionnaire, the clinical symptoms and signs of a single overall score and score symptoms and signs. Clinical efficacy and safety in accordance with time-phased medication was evaluated. The results show that Gubiqing-Recipe can significantly improve the KOA complicated with gonarthro- meningitis patients’TCM systemic symptoms, physiological functions,symptoms and signs. The Gubiqing-Recipe group curative effect surpasses the Xinhuang Tablet group. In observation period curative effect superiority along with treatment time expands. Gubiqing-Recipe has not obvious poisonous side reaction and has highly the security. We raise the OA-FLS cells in vitro of KOA complicated with gonarthromeningitis patients’synovial membrane, and observe the influence of different concentrations Gubiqing-Recipe and Xinhuang Tablet on cell growth and proliferation by MTT, flow cytometry and RT-PCR methods. The results show that Gubiqing-Recipe and Xinhuang Tablet can suppress the OA-FLS multiplication. Two medicines may suppress the OA-FLS mitosis in the physiological dosage, reduces the S time, lengthens the G1 time and the highly concentrated Gubiqing-Recipe can induce the OA-FLS cell apoptosis. Gubiqing-Recipe can obviously inhibited c-fos and COX-2 mRNA expressions of OA-FLS. Conclusion: Gubiqing-Recipe of clearing heat, detoxication, dispelling damp can inhibit OA-FLS cells’proliferation and differentiation directly from the transcription level. Gubiqing-Recipe display conformity control action through multi-ways, multi-links and multi-target. Gubiqing-Recipe can reverse basic pathogenesis that blockage of hot, damp, stasis and poisonous, restrain inflammation of synovium , decrease cartilage destruction, yield a radical cure of KOA complicated with gonarthromeningitis.
引文
[1] Sarzi-Puttini P, Cimmino MA, Scarpa R, et al. Osteoarthritis: An Overview of the Disease and Its Treatment Strategies[J].Semin Arthritis Rheum, 2005,35 (suppl 1):11.
[2]陈百成,张静.骨关节炎[M].北京:人民卫生出版社,2004:452-456.
[3]张乃峥,施全胜,张雪哲,等.膝骨关节炎的流行病学调查[J].中华内科杂志.1995;34(2):84-87.
[4]中华医学会风湿病学分会.骨关节炎诊治指南(草案)[J].中华风湿病学杂志,2003,7(11):702-724.
[5]张志.骨科腱囊病[M].郑州:郑州大学出版社,2001:213-214.
[6] Lawrence M.Indice of severity and disease activity for osteoarthritis [J].Semin Arthritis Rheum, 1991,20(12):48.
[7]郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002;349-353.
[8] Mckenna F, Borenstein D, Wednt H. Celecoxib versus diclofenac in the management of Osteoarthritis of the knee[J]. Scand J Rheumatology, 2000,30(1):11-18.
[9] Reginster JY, Deroisy R, Rovati LC. long term effects of glucosamine sulphate on Osteoarthritis progression, a randomized placed controlled clinical trial[J]. Lanoet, 2001,357(9252): 251-256.
[10] Bellamy N, Buchanan W, Goldsmith CH, et al. validation study of WOMAC, a health status instrument for measuring clinical important patient relevant outcomers to antirheumatic drug therapy in patients with OA of the hip or knee[J]. J Rheumatol,1988,15:1833-1840.
[11] Lingard EA, Katz JN, Wright RJ. Validity and Resoniseness of the Knee Society Clinical Rating System in comparison with the SF-36 and WOMAC[J].J Bone Joint Surg Am,2001,83A(12):1856-1864.
[12]高益民.膝关节骨关节炎Ⅱ期临床试验方案(征求意见稿)[J].中药新药与临床药理,1998,9(1):16-18.
[13]陈英.三七总苷的药理研究及临床应用进展[J].广西医学,1998,20(6):1109.
[14]蒋伟哲,孔晓龙,黄仁彬,等.肿节风片的抗菌和抗炎作用研究[J].广西中医学院学报,2000,17(1):50.
[15]宋立人,洪询,丁绪亮,等.现代中药学大词典[M].北京:人民卫生出版社,2001:51-68.
[16]赵诗云,彭旦明,周名智,等.肿节风对小鼠白细胞和血小板的影响[J].上海实验动物科学,2000,20(3):154.
[17]郑跃进.新癀片治疗小儿髋关节暂时性滑膜炎[J].中成药,1995,17(10):50.
[18]尚娟.新癀片治疗湿热痹疗效观察[J].医药论坛杂志. 2007,28(13):98.
[19] Fiorito S, Magrini L, Adrey J, et al. Inflammatory status and cartilage regenerative potential of synovial fibroblasts from patients with osteoarthritis and chondropathy. Rheumatology (Oxford),2005,44:164-171.
[20] Benito MJ, Veale DJ,Fitz-Gerald O, et al. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis, 2005,64:1263-1267.
[21]中华人民共和国国家药典委员会.中国药典(一部).北京:化学工业出版杜,2000,265
[22]阴健,《中药现代研究与临床应用II》[M],北京:学苑出版社,1993,10.
[23]刘圣,沈爱宗.土茯苓研究进展[J].中医药学报,1997,(5):54-56.
[24]徐强,王蓉,徐丽华,等.土茯苓对细胞兔疫和体液免疫的影响[J].中国免疫学杂志,1993,9(1):39.
[25]张白嘉,刘亚欧,刘榴,等.土茯苓及落新妇苷抗炎、镇痛、利尿作用研究[J].中药药理与临床,2004,20(1):11-12.
[26]杨霓芝,黄春林.泌尿专科中医临床诊治[M].北京:人民卫生出版社,2000:275-309.
[27]吕燕宁,邱全瑛.黄柏对小鼠DTH及其体内几种细胞因子的影响[J].北京中医药大学学报,1999,22(6):48-50.
[28]王衡奇,秦民坚,余国奠,黄柏的化学成分及药理学研究进展[J],中国野生植物资源,2001,20(4),6-8.
[29]黄泰康.常用中药成分与药理手册[M],北京:中国医药科技出版社,1994:1604.
[30]张明发,沈雅琴,朱自平,等.薏苡仁镇痛抗炎抗血栓形成作用的研究[J].第三军医大学学报,2000,22(6):578.
[31]张明发,沈雅琴,朱自平,等.薏苡仁镇痛抗炎抗血栓形成作用的研究[J].基层中药杂志,1998,12(2):34.
[32]王玉萍.薏苡仁汤治疗膝关节滑膜炎90例-附西医常规疗法治疗30例对照[J].浙江中医杂志,2005,40(4):165.
[33]孙连娜,洪永福,郭学敏.光皮木瓜化学成分的研究Ⅱ[J].第二军医大学学报,1999,20(10):752-754.
[34] ROH S B, CHANG E H, IM KS, et al. Isolation and characterization of acidic triterpenes from the fruits of Chaenomeles sineosis[J].Yakhak Hoeji,1995,39(2):610-615.
[35] ZHANG Ling-ling, WEI Wei, YAN Shang-xue. Therapeutic effects of glucosides of Chaenomeles sinensis on collagen-induced arthritis in mice[J].Acta Pharxnacologica Sinica,2004,25(11):1495-1501.
[36]胡世林,付桂兰,冯学锋,等.不同产地和部位赤芍中芍药苷的含量测定[J].中国中药杂志,2000,25(12):714-716.
[37]刘超,王静,杨军.赤芍总甙活血化瘀作用的研究[J].中药材,2000,23(9):557-601.
[38]阮金兰,赵钟祥,曾庆忠,等.赤芍化学成分和药理作用的研究进展[J].中国药理学通报,2003,19(9):965-969.
[39]刘晓天,汤汉芬,须育方.中药成分芍药甙、苦参碱及氯化苦参碱对膜酶作用的实验研究[J].中国药学杂,1993,28(11):658-660.
[40]段径云.鹿蹄草的抗炎作用[J].陕西中医,1992,13(9):42.
[41]王军宪,陈新民,李宏,等.鹿衔草化学成分的研究:经基肾叶鹿蹄草普的结构鉴定[J].植物学报,1994,36(11):395.
[42]董民声,李全民.复方黄蔑注射液对庆大霉素肾毒性拮抗作用实验研究[J].广西医学,1995,17(1):171.
[43]柯铭清.中草药有效成分理化与药理特性[M].长沙:湖南科学技术出版社,1982:611.
[44]马振亚.鹿蹄草等中草药方剂对细胞免疫功能的影响[J].陕西新医药,1984,13(6):541.
[45]叶品良,彭娟,刘娟.川牛膝研究概况[J].中医药学报,2007,35(2):51-53.
[46]史玉芬,郑延彬,牛膝抗炎、抗病毒作用的研究[J].中药通报, 1988,13(7):44.
[47] Raphael T J, Kuttan G. Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system[J]. Phytomedicine, 2003,10(67): 483-489.
[48] Froemming G R, O'Brien N M. U937 Cells as A Model to Study the Effect of Phytochemicals on Superoxide Anion Production[J]. Nutrition Research, 1997, 17(7): 1091-1103.
[49]江伟达,郑效文,郑清波,等.中药关节Ⅲ号方治疗家兔膝骨关节炎的实验研究[J].中国中医骨伤科,1994,2(1):1-3.
[50]石印玉,汪青春,沈培芝,等.分期论治膝关节炎的对比研究[J].中国学术期刊文摘,1997,3(7):890.
[51]沈培芝,石印玉,陈友红,等.强筋方治疗试验性膝骨关节炎的组织病理学观察研究[J].中国中医骨伤科,1997,3(1):11.
[52]郭丽丽,周勇.山茱萸总苷对关节炎大鼠原代滑膜细胞培养上清趋化能力的影响[J].北京中医药大学学报,2002,25(3):30.
[53]孟祥奇,惠衤乃华,姜宏,等.化痰祛湿剂对兔膝骨关节炎血清中SOD、NO的影响[J].中医药学报,2007,35(2):21-23.
[54]高文香,刘元禄,等.补肾法防治兔膝关节骨关节炎的病理形态学观察[J].中医正骨,1999,11(11):13-16.
[55]樊粤光,谢国平.补肝肾方血清对体外培养大鼠软骨细胞的影响[J].中药新药与临床药理,2004,15(4):257-258.
[56]冯伟,石印玉,沈培芝,等.中药对软骨细胞代谢的影响[J].中国中医骨伤杂志,2000,8(2):9-11.
[57]王秀华,刘元禄,苏姿兵,等.丹参关节内注射对兔膝骨关节炎细胞因子IL-1及TNF的影响[J].中医正骨,2003,15(10):1-3.
[58]汪青春,石印玉,沈培芝.中药对膝OA小鼠关节软骨IL-1,iNOS基因表达的影响[J].山西医药杂志,1999,28(5):381.
[59]叶伟成,李文,石印玉,等.不同中药对小鼠关节滑膜组织释放白细胞介素-1的影响的实验研究[J].上海市中医药研究学院学报,1995,9(1):59.
[60]施旭光,张声鹏,徐志东.白虎追风丸对大鼠佐剂性关节炎滑膜细胞分泌IL-1β的影响[J].中成药,2001,23(8):595.
[61]陈述祥,司徒坚,杨运东,等.自制复方中药对膝骨关节炎家兔血液流变及病理形态的影响[J].中国临床康复,2005,9(30):147-149.
[62]于培俊.川芎嗪注射液治疗膝骨关节炎30例[J].实用中医内科杂志,2005,19(5):473.
[63]黄涛,徐传毅,邹季,等.活血止痛汤治疗早期骨关节炎的实验研究[J].中医正骨,1999,11(5):3.
[64]许学猛,王羽丰,邓晋丰,等.补肾活血胶囊影响兔膝关节退变性疾病骨内压变化的实验研究[J].中国中医骨伤科杂志,2001,9(4):24.
[65]王济纬,杜宁,等.中药对实验性骨关节炎膝旁骨内压的影响[J].中医正骨1997,9(4):3-5.
[66]万荣,杨庆铭,邓廉夫.黑虎丹治疗兔骨关节炎的实验研究[J].中国骨伤, 2001,14(2): 85-87.
[67]刘健,韩明向,翟志敏,等.新风胶囊对佐剂性关节炎大鼠滑膜细胞凋亡的影响[J].中国临床保健杂志,2005,4(8):296.
[68]潘浩,胡庆丰,李雄峰,等.补肾壮筋汤对兔早期实验性膝骨关节炎软骨细胞凋亡及增殖细胞核抗原表达的影响[J].中国骨伤,2005,18(5):278-281.
[69]乐宇民,杜建骨.关节炎I号方对抗过氧化氢致软骨细胞DNA的损伤作用[J].中国临床康复,2005,9(18):103-106.
[70]牛维,邵敏,黎高明.补肾活血方对膝骨关节炎模型家兔一氧化氮水平的影响[J].安徽中医学院学报,2005,24(3):26-28.
[71]汪青春,董慧芳,沈培芝,等.中药对膝关节炎黑鼠血清SOD、HA、NO水平的影响[J].中医正骨,1999,11(5):5.
[72]杨平林,刘德玉,贺西京,等.补肾活血中药对膝骨关节炎家兔血清、滑膜及关节软骨一氧化氮水平的影响[J].中国正骨,2003,16(11):667-669.
[73]李宇明,杨运东,陈述祥.关节内冲洗并内服中药对膝骨关节炎患者氧自由基代谢的影响[J].中国中西医结合外科杂志.2004,10(3):151-153.
[74]蔡余力,李刚,颜冰,等.补肾壮骨胶囊治疗膝关节骨关节炎的实验研究[J].中医正骨.2006,18(6):1-4.
[75]黄枫,唐勇,郑晓辉.补肾强膝方对绝经后妇女膝骨关节炎的影响[J].中医正骨,2002,14(4): 12.
[76]牛维,刘海全.补肾中药对膝骨关节炎合并绝经后骨质疏松症骨密度、雌激素水平的影响[J].北京中医药大学学报,2005,28(4):69-71
[77] Zhang F, Warskulat U, Wettstein M, et al. Hyperosmolarity stimulates prostag landin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages[J]. Biochem J, 1995,312(Pt 1):135-143.
[78] Myers LK,Kang AH, Postlethwaite AE,et al. The genetic ablation of cyclooxygenase-2 prevents the development of autoimmune arthritis[J]. Arthritis Rheum,2000,43(12):2687-2693.
[80] Song Y G,Kwon H M, Kim J M,et al.Serologic and histopathologic study of chlamydia pneumoniae infection in atherosclerosis: a possible pathogenetic mechanism of atherosclerosis induced by chlamydia pneumoniae[J]. Yonsei Med J,2000,41(3):319-327.
[81] Speir E,Yu Z X, Ferrans V J,et al. Aspirin attenuates cytomegalovirus in ectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells[J]. Circ Res,1998,83(2):210-216.
[82] Tsujii M, Kawano S, DuBois RN, et al. Cyclooxygenase regulation angiogenesis induced by colon cancer cells[J]. Cell, 1998,93(5):705-716.
[83] N Kumahashi, M Ochi, Kataoka H, et al. Involvement of ATP, increase of intracellular calcium and the early expression of c-fos in the repair of rat fetal articular cartilage[J]. Cell Tissue Res 2004,317(2):117-28.
[84]邓凌霄,林建华.c-fos基因的表达与软骨的增殖及分化[J].中国临床康复.2006,10(l):138-141.
[85] Hassan Fahmi, DiBattista JA, Pelletier JP, et al. Peroxisome proliferatoractivated receptor gamma activators inhibit inter- leukin -lbeta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes[J]. Arthritis Rheum, 2001,44(3):595-607.
[1]娄思权.骨关节炎的病理与发病因素[J].中华骨科杂志,1996,16(1):56.
[2]娄玉钤.中国风湿病学(第1版)[M].北京:人民卫生出版社,2001,130-133.
[3]张如明.退变性膝骨关节病病因的实验观察和临床治疗的初步报告[J].中华骨科杂志,1994,14(10):612-614.
[4]张毓洲,许露玫,许振华,等.正常与骨内高压下骨髓微循环冷冻割断扫描电镜观察[J].中华骨科杂志,1999,19(5):303-306.
[5] Dey A.Effect of high tibialo osteotony on uppertibial venors drainage: Study by intraosseous phlebog-raphy in primary osteoarthritis of knee joint[J]. Ann Rheum Dis,1989,48:188-195.
[6]陈清汉,许振华,刘家勇,等.膝部疼痛与骨内压关系的临床研究[J].中华骨科杂志,1996,16(1):25-28.
[7] Rourne K S, I Ke RW. Diagnostic arthroscopy in the thearthritis patient[J]. Rheum D Clinics of North Am,1994,120:321-342.
[8]郑福增,程少丹.骨疏康治疗绝经后妇女膝关节功能障碍的疗效观察[J].中国临床康复,2004,8(17):3322-3323.
[9]阮祥燕,刘玉兰,彭舟丽,等.强骨胶囊对绝经后膝骨关节炎妇女膝关节有效活动度的影响[J].中国临床康复,2005,9(19):170-171.
[10]陈小凯,吴虹.巨刺治疗膝骨关节炎81例疗效观察[J].针灸临床杂志,2003,19(8):53.
[11]张颇,张闻生,邹季.风湿骨痛药酒药褪外治法治疗兔膝关节骨关节炎的实验研究[J].中医正骨,2001,13(7):9.
[12]舒强,李兴福,侯怀水,等.艾拉莫德对骨关节炎滑膜成纤维样细胞特性的影响.中华风湿病学杂志,2006,10(7):389-392.
[13] Benito MJ, Veale DJ, Fitz-Gerald O, et al. Synovial tissue inflammation in early and late osteoarthritis[J]. Ann Rheum Dis,2005,64:1263-1267.
[14]王巨,肖德明,李伟,5-氟脲嘧啶关节腔注射治疗兔膝骨关节炎的实验研究[J],中国矫形外科杂志,2006,9(17):1339-1341.
[15]董建勇,赵晓薇,李立.附桂关节汤防治骨关节炎作用形态学观察[J].甘肃中医学院学报,1997,14(1):27.
[16]许学猛,王羽丰,邓晋丰,等.补肾活血胶囊影响兔膝关节退变性疾病骨内压变化的实验研究[J].中国中医骨伤科杂志,2001,9(4):24.
[17]张德辉,薛刚,黄昌林.应用玻璃酸钠对关节镜术后膝骨关节炎功能恢复的影响[J].中国临床康复,2002,6(12):1730.
[18]龚权.细胞凋亡与骨关节炎研究进展[J].湖北省卫生职工医学院学报.2004,17(4):92-94.
[19] Hashimoto S,Setareh M,Roseen F,et al.Fas/Fas ligand expression and induction of apoptosis in chondrocytes[J]. Arthritis Rheum,1997,40 (10):1749.
[20] Pelletier JP,Fernandes JC,Jovanovic DV. Chondrocyte death in expertimental osteoarthritis is mediated by MEK1/2 and p38 pathways: role of cycle oxygenase-2 and inducible nitric oxide synthase[J]. J Rheumatol,2001,28 (11):2509.
[21] Heraud F,Heraud A,Harmand MF. Apoptosis in normal and osteoarthric human articular cartilage[J].Ann Rheum Dis,2000,59(12):9594.
[22] Hashimoto S,Ochs RL,Komiya S,Lotz M. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis[J]. Arthritis Rheum,1998,41 (9):1632.
[23] Miwa M,Saura R,Hirata S,et al. Induction of apoptosis in bovine articular chondrocyte by prostaglandin E(2) through cAMP-dependent pathway[J].Osteoarthritis Cartilage,2000,8(1):17.
[24] Kuhn K,Hashimoto S,Lotz M. Cell density modulates apoptosis in human articular chondrocytes[J].J Cell Physiol,1999,180 (3):439.
[25] Erlacher L,Maier R,Ullrich R,et al. Differential expression of the protooncogene bcl-2 in normal and steoarthritic human articular cartilage[J].J Rheumatol,1995,22 (5):926.
[26] Kim SJ,Hwang SG,Shin DY,et al. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NF-kappa B -dependent transcription and stabilization by serine 15 phosphory- lation[J].J Biol Chem,2002,277 (36):33501.
[27] Mukherjee P,Rachita C,Aisen PS,et al. Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death[J].Clin Exp Rheumatol,2001,19 (1):57.
[28] Pelletier JP,Jovanovic DV,Lascau-Coman V,et al. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo:possible link with there duction in chondrocyte apoptosis and caspase3 level[J].Arthritis Rheum,2000,43(6):1290.
[29] Cao L,Yang B. Chondrocyte apoptosis induced by aggree an G1 domain as a result of decreased cell adhesion[J].Exp Cell Res,1999,246(2):527.
[30]吕红斌,朱洁,胡建中,等.骨关节病滑膜细胞凋亡和癌基因的表达[J].中国运动医学杂志,1998,17 (4):296.
[31] Hacker G,Vaux DL. The medical significance of physiological cell death[J].Med Res Rev.1995,15:299-311.
[32] Susin SA,Zamzami N,Castedo M,et al. Bc1-2 inhibits the mitochondrial release of an apoptogenic protease[J]. J Exp Med 1996,184:1331-1341.
[33] Jovanovic DV,Mineau F,Notoya K,et al.Nitricoxide induced cell death inhuman osteoarthriticsynoviocytes is mediated by tyrosine kinase activation and hydrogen peroxide and/or superoxide formation[J]. J R heumatol,2002,29 (10):2165.
[34] Okamoto K,Kobayashi T,Kobata T,et al. Fas-associated death domain protein is a Fas-mediated apoptosis modulator in synoviocytes[J].Rheumatology (Oxford),2000,39 (5):471.
[35]蔡伟平,汤亭亭.骨关节炎的细胞生物学研究进展[J].国外医学·骨科学分册,2004,25(1),18-21.
[36] Pelletier JP,DiBattista JA,Routhley P,et al. Cytokines and inflammation in cartilage degradation[J]. Rheum Dis Clin North Am,1993,19:545-568.
[37]张洪斌.骨关节炎的基因治疗[J].中国临床康复,2003,7(32):4390-4391.
[38] Frnandes JC,Martel PJ,Pelletier JP. The role of cytokinesin osteoar thritis pathophysiology[J]. Biorheology,2002,39:237-246.
[39] Smith MD,Triantafillou S,Parker A,et al.Synovial membrane inflammation and cytokine production in patients with early osteoarthritis[J].J Rheumatol,1997,24:365-371.
[40] Pelletier JP,Caron JP,Evans CH,et al.Invivo suppression of early experimental osteoarthritis by interleukin 21 receptorant agonist usinggene therapy[J]. ArthritisRheum,1997,40:1020-1019.
[41] Arner EC,Harris RR,Dimeo TM,et al.Inter leukin21 receptor antagonist inhibits proteogly can break down inantigen induced but not polycation induce darthritis intherabbit[J]. J Rheumatol.1995,22:1338-1346.
[42] Makarov SS,Olsen JC,Johnston WN,et al.Suppression of experimental arthritis by gene tranfer of interleukin 21 receptor antagonistc DNA[J]. Proc Natl Acad Sci USA,1996,93:402-406.
[43] Hashimoto S,Takahashi K,Amiel D,et al.Chondrocy teapoptosis and nitric oxide production during experimentally induced osteoarthritis[J]. Arthritis Rheum,1998,41:1266-1274.
[44] Otani K,Nita I,MaCaulay W,et al.Suppression of antigen 2 induced arthritis by gene therapy[J]. J Immunol,1996,156:3558-3562.
[45]杨尚云,狄春辉,蒋明,等.白介素21受体拮抗剂基因治疗小鼠型胶原关节炎的疗效观察[J].中华医学杂志,2002,82:990-994.
[46] Yang GY, Di CH, Jiang M, et al. Effect of inter leukin 2 receptor antigonist gene therapy on arthritis induced by type collagenin mice[J]. Natl Med J China, 2002, 82:990-994.
[47] Evans CH, Ghivizzani SC, Kang R, et al. Genetherapy for rheumatic diseases[J]. Arthritis Rheum, 1999,42:1216.
[48] Smith GN Jr,Yu LP Jr,Brandt KD,et al . Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage[J]. J Rheumatol,1998,25(3:532-535.
[49] Billinghurst RC,Dahlberg L,Ionescu M,et al . Enhenced cleavage of typeⅡcollagenases in osteoarthritic cartilage[J].J Clin Invest. 1997,99(7):1534-1545.
[50]管剑龙,韩星海,施桂英,等.细胞因子和药物对软骨细胞和滑膜细胞金属蛋白酶活性的调节[J].第二军医大学学报,2000,11(9),861-864.
[51] Clegg PD,Burke RM,Coughlan AR,et al . Characterization of equine matrix Metalloproteinase 2 and 9,and identification of the cellular sources of these enzymes in joints[J]. Equine Vet J,1997,29(5):335-342.
[52] Takahashi S,Inoue T,Higaki M,et al . Cyclooxygenase inhibitors enhance the production of tissue inhibitor-1βof metalloproteinases( TIMP-1)and pro-matrix metalloproteinase-1(pro MMP-1)in human rheumatoid synovial fibroblasts [J]. Inflamm Res,1997,46(8):320-323.
[53]管剑龙,施桂英,韩星海,等.骨关节炎软骨细胞和滑膜细胞金属蛋白酶活性的影响因素[J].中华风湿病学杂志2001,5(1):19-22.
[54]邓凌霄,林建华.c-fos基因的表达与软骨的增殖及分化[J].中国临床康复,2006,10(l),138-141.
[55] S Riemer,S Gebhard, Beier F,et al. Role of c-fos in the regulation of type X collagen gene expression by PTH and PTHrP: localization of a PTH/P'PHrP-responsive region in the human enhancer[J].J Cell Biochem.2002,86(4): 688-699.
[56] TF Li,MJ Zuscik,Ionescu AMet al. PGE2 inhibits chondrocyte differ-entiation through PKA and PKC signaling[J]. Exp Cell Res 2004,300(1):159-169.
[57] N Kumahashi,M Ochi,Kataoka H,et al. Involvement of ATP,increase of intracellular calcium and the early expression of c-fos in the repair of rat fetal articular cartilage[J].Cell Tissue Res 2004,317(2):117-128.
[58] M Benderdour,G Tardif,Pelletier JP,et al. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1 beta[J].J Rheumatol. 2002,29(6):1262-1272.
[59] JB Catterall, S Carrere, Koshy PJ, et al.Synergistic induction of matrix metalloproteinase 1 by interleukin-lalpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism[J]. Arthritis Rheu. 2001,44(10): 296-310.
[60] Hassan Fahmi,DiBattista JA,Pelletier JP,et al. Peroxisome proliferator activated receptor gamma activators inhibit interleukin-lbeta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes[J].Arthritis Rheum 2001,44(3):595-607.
[61] Martin G,Andriamanalijaona R,Grassel S,et al.Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes[J]. Arthritis Rheu ,2004,50(11): 3549-60.
[62] MP Morgan,McC arthy GM. Signaling mechanisms involved in crystal-induced tissue damage[J].Curr Opin Rheumatol.2002,14(3):292-297.
[63] Morita I,Schindler M,Regier M K,et al.Different intracellular locations for prostaglandin endoperoxide H synthase-1 and 2[J].J Biol Chem,1995,270(18):10902-10908.
[64] Song Y G,Kwon H M,Kim J M,et al.Serologic and histopathologic study of chlamydia pneumoniae infection in atherosclerosis:a possible pathogenetic mechanism of atherosclerosis induced by chlamydia pneumoniae[J].Yonsei Med J,2000,41(3):319-327.
[65] Speir E,Yu Z X,Ferrans V J,et al.Aspirin attenuates cytomegalovirus in ectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells[J].Circ Res,1998,83(2):210-216.
[66] Stanford S J,Pepper J R,Mitchell J A.Cyclooxygenase-2 regulatesgranulocyte-macrophage colony-stimulating factor,but not interleukin-8,production by human vascular cells:role of cAMP[J].Arterioscler Thromb Vasc Biol,2000,20(3):677-682.
[2]陈百成,张静.骨关节炎[M].北京:人民卫生出版社,2004:452-456.
[3]张乃峥,施全胜,张雪哲,等.膝骨关节炎的流行病学调查[J].中华内科杂志.1995;34(2):84-87.
[4]中华医学会风湿病学分会.骨关节炎诊治指南(草案)[J].中华风湿病学杂志,2003,7(11):702-724.
[5]张志.骨科腱囊病[M].郑州:郑州大学出版社,2001:213-214.
[6] Lawrence M.Indice of severity and disease activity for osteoarthritis [J].Semin Arthritis Rheum, 1991,20(12):48.
[7]郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002;349-353.
[8] Mckenna F, Borenstein D, Wednt H. Celecoxib versus diclofenac in the management of Osteoarthritis of the knee[J]. Scand J Rheumatology, 2000,30(1):11-18.
[9] Reginster JY, Deroisy R, Rovati LC. long term effects of glucosamine sulphate on Osteoarthritis progression, a randomized placed controlled clinical trial[J]. Lanoet, 2001,357(9252): 251-256.
[10] Bellamy N, Buchanan W, Goldsmith CH, et al. validation study of WOMAC, a health status instrument for measuring clinical important patient relevant outcomers to antirheumatic drug therapy in patients with OA of the hip or knee[J]. J Rheumatol,1988,15:1833-1840.
[11] Lingard EA, Katz JN, Wright RJ. Validity and Resoniseness of the Knee Society Clinical Rating System in comparison with the SF-36 and WOMAC[J].J Bone Joint Surg Am,2001,83A(12):1856-1864.
[12]高益民.膝关节骨关节炎Ⅱ期临床试验方案(征求意见稿)[J].中药新药与临床药理,1998,9(1):16-18.
[13]陈英.三七总苷的药理研究及临床应用进展[J].广西医学,1998,20(6):1109.
[14]蒋伟哲,孔晓龙,黄仁彬,等.肿节风片的抗菌和抗炎作用研究[J].广西中医学院学报,2000,17(1):50.
[15]宋立人,洪询,丁绪亮,等.现代中药学大词典[M].北京:人民卫生出版社,2001:51-68.
[16]赵诗云,彭旦明,周名智,等.肿节风对小鼠白细胞和血小板的影响[J].上海实验动物科学,2000,20(3):154.
[17]郑跃进.新癀片治疗小儿髋关节暂时性滑膜炎[J].中成药,1995,17(10):50.
[18]尚娟.新癀片治疗湿热痹疗效观察[J].医药论坛杂志. 2007,28(13):98.
[19] Fiorito S, Magrini L, Adrey J, et al. Inflammatory status and cartilage regenerative potential of synovial fibroblasts from patients with osteoarthritis and chondropathy. Rheumatology (Oxford),2005,44:164-171.
[20] Benito MJ, Veale DJ,Fitz-Gerald O, et al. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis, 2005,64:1263-1267.
[21]中华人民共和国国家药典委员会.中国药典(一部).北京:化学工业出版杜,2000,265
[22]阴健,《中药现代研究与临床应用II》[M],北京:学苑出版社,1993,10.
[23]刘圣,沈爱宗.土茯苓研究进展[J].中医药学报,1997,(5):54-56.
[24]徐强,王蓉,徐丽华,等.土茯苓对细胞兔疫和体液免疫的影响[J].中国免疫学杂志,1993,9(1):39.
[25]张白嘉,刘亚欧,刘榴,等.土茯苓及落新妇苷抗炎、镇痛、利尿作用研究[J].中药药理与临床,2004,20(1):11-12.
[26]杨霓芝,黄春林.泌尿专科中医临床诊治[M].北京:人民卫生出版社,2000:275-309.
[27]吕燕宁,邱全瑛.黄柏对小鼠DTH及其体内几种细胞因子的影响[J].北京中医药大学学报,1999,22(6):48-50.
[28]王衡奇,秦民坚,余国奠,黄柏的化学成分及药理学研究进展[J],中国野生植物资源,2001,20(4),6-8.
[29]黄泰康.常用中药成分与药理手册[M],北京:中国医药科技出版社,1994:1604.
[30]张明发,沈雅琴,朱自平,等.薏苡仁镇痛抗炎抗血栓形成作用的研究[J].第三军医大学学报,2000,22(6):578.
[31]张明发,沈雅琴,朱自平,等.薏苡仁镇痛抗炎抗血栓形成作用的研究[J].基层中药杂志,1998,12(2):34.
[32]王玉萍.薏苡仁汤治疗膝关节滑膜炎90例-附西医常规疗法治疗30例对照[J].浙江中医杂志,2005,40(4):165.
[33]孙连娜,洪永福,郭学敏.光皮木瓜化学成分的研究Ⅱ[J].第二军医大学学报,1999,20(10):752-754.
[34] ROH S B, CHANG E H, IM KS, et al. Isolation and characterization of acidic triterpenes from the fruits of Chaenomeles sineosis[J].Yakhak Hoeji,1995,39(2):610-615.
[35] ZHANG Ling-ling, WEI Wei, YAN Shang-xue. Therapeutic effects of glucosides of Chaenomeles sinensis on collagen-induced arthritis in mice[J].Acta Pharxnacologica Sinica,2004,25(11):1495-1501.
[36]胡世林,付桂兰,冯学锋,等.不同产地和部位赤芍中芍药苷的含量测定[J].中国中药杂志,2000,25(12):714-716.
[37]刘超,王静,杨军.赤芍总甙活血化瘀作用的研究[J].中药材,2000,23(9):557-601.
[38]阮金兰,赵钟祥,曾庆忠,等.赤芍化学成分和药理作用的研究进展[J].中国药理学通报,2003,19(9):965-969.
[39]刘晓天,汤汉芬,须育方.中药成分芍药甙、苦参碱及氯化苦参碱对膜酶作用的实验研究[J].中国药学杂,1993,28(11):658-660.
[40]段径云.鹿蹄草的抗炎作用[J].陕西中医,1992,13(9):42.
[41]王军宪,陈新民,李宏,等.鹿衔草化学成分的研究:经基肾叶鹿蹄草普的结构鉴定[J].植物学报,1994,36(11):395.
[42]董民声,李全民.复方黄蔑注射液对庆大霉素肾毒性拮抗作用实验研究[J].广西医学,1995,17(1):171.
[43]柯铭清.中草药有效成分理化与药理特性[M].长沙:湖南科学技术出版社,1982:611.
[44]马振亚.鹿蹄草等中草药方剂对细胞免疫功能的影响[J].陕西新医药,1984,13(6):541.
[45]叶品良,彭娟,刘娟.川牛膝研究概况[J].中医药学报,2007,35(2):51-53.
[46]史玉芬,郑延彬,牛膝抗炎、抗病毒作用的研究[J].中药通报, 1988,13(7):44.
[47] Raphael T J, Kuttan G. Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system[J]. Phytomedicine, 2003,10(67): 483-489.
[48] Froemming G R, O'Brien N M. U937 Cells as A Model to Study the Effect of Phytochemicals on Superoxide Anion Production[J]. Nutrition Research, 1997, 17(7): 1091-1103.
[49]江伟达,郑效文,郑清波,等.中药关节Ⅲ号方治疗家兔膝骨关节炎的实验研究[J].中国中医骨伤科,1994,2(1):1-3.
[50]石印玉,汪青春,沈培芝,等.分期论治膝关节炎的对比研究[J].中国学术期刊文摘,1997,3(7):890.
[51]沈培芝,石印玉,陈友红,等.强筋方治疗试验性膝骨关节炎的组织病理学观察研究[J].中国中医骨伤科,1997,3(1):11.
[52]郭丽丽,周勇.山茱萸总苷对关节炎大鼠原代滑膜细胞培养上清趋化能力的影响[J].北京中医药大学学报,2002,25(3):30.
[53]孟祥奇,惠衤乃华,姜宏,等.化痰祛湿剂对兔膝骨关节炎血清中SOD、NO的影响[J].中医药学报,2007,35(2):21-23.
[54]高文香,刘元禄,等.补肾法防治兔膝关节骨关节炎的病理形态学观察[J].中医正骨,1999,11(11):13-16.
[55]樊粤光,谢国平.补肝肾方血清对体外培养大鼠软骨细胞的影响[J].中药新药与临床药理,2004,15(4):257-258.
[56]冯伟,石印玉,沈培芝,等.中药对软骨细胞代谢的影响[J].中国中医骨伤杂志,2000,8(2):9-11.
[57]王秀华,刘元禄,苏姿兵,等.丹参关节内注射对兔膝骨关节炎细胞因子IL-1及TNF的影响[J].中医正骨,2003,15(10):1-3.
[58]汪青春,石印玉,沈培芝.中药对膝OA小鼠关节软骨IL-1,iNOS基因表达的影响[J].山西医药杂志,1999,28(5):381.
[59]叶伟成,李文,石印玉,等.不同中药对小鼠关节滑膜组织释放白细胞介素-1的影响的实验研究[J].上海市中医药研究学院学报,1995,9(1):59.
[60]施旭光,张声鹏,徐志东.白虎追风丸对大鼠佐剂性关节炎滑膜细胞分泌IL-1β的影响[J].中成药,2001,23(8):595.
[61]陈述祥,司徒坚,杨运东,等.自制复方中药对膝骨关节炎家兔血液流变及病理形态的影响[J].中国临床康复,2005,9(30):147-149.
[62]于培俊.川芎嗪注射液治疗膝骨关节炎30例[J].实用中医内科杂志,2005,19(5):473.
[63]黄涛,徐传毅,邹季,等.活血止痛汤治疗早期骨关节炎的实验研究[J].中医正骨,1999,11(5):3.
[64]许学猛,王羽丰,邓晋丰,等.补肾活血胶囊影响兔膝关节退变性疾病骨内压变化的实验研究[J].中国中医骨伤科杂志,2001,9(4):24.
[65]王济纬,杜宁,等.中药对实验性骨关节炎膝旁骨内压的影响[J].中医正骨1997,9(4):3-5.
[66]万荣,杨庆铭,邓廉夫.黑虎丹治疗兔骨关节炎的实验研究[J].中国骨伤, 2001,14(2): 85-87.
[67]刘健,韩明向,翟志敏,等.新风胶囊对佐剂性关节炎大鼠滑膜细胞凋亡的影响[J].中国临床保健杂志,2005,4(8):296.
[68]潘浩,胡庆丰,李雄峰,等.补肾壮筋汤对兔早期实验性膝骨关节炎软骨细胞凋亡及增殖细胞核抗原表达的影响[J].中国骨伤,2005,18(5):278-281.
[69]乐宇民,杜建骨.关节炎I号方对抗过氧化氢致软骨细胞DNA的损伤作用[J].中国临床康复,2005,9(18):103-106.
[70]牛维,邵敏,黎高明.补肾活血方对膝骨关节炎模型家兔一氧化氮水平的影响[J].安徽中医学院学报,2005,24(3):26-28.
[71]汪青春,董慧芳,沈培芝,等.中药对膝关节炎黑鼠血清SOD、HA、NO水平的影响[J].中医正骨,1999,11(5):5.
[72]杨平林,刘德玉,贺西京,等.补肾活血中药对膝骨关节炎家兔血清、滑膜及关节软骨一氧化氮水平的影响[J].中国正骨,2003,16(11):667-669.
[73]李宇明,杨运东,陈述祥.关节内冲洗并内服中药对膝骨关节炎患者氧自由基代谢的影响[J].中国中西医结合外科杂志.2004,10(3):151-153.
[74]蔡余力,李刚,颜冰,等.补肾壮骨胶囊治疗膝关节骨关节炎的实验研究[J].中医正骨.2006,18(6):1-4.
[75]黄枫,唐勇,郑晓辉.补肾强膝方对绝经后妇女膝骨关节炎的影响[J].中医正骨,2002,14(4): 12.
[76]牛维,刘海全.补肾中药对膝骨关节炎合并绝经后骨质疏松症骨密度、雌激素水平的影响[J].北京中医药大学学报,2005,28(4):69-71
[77] Zhang F, Warskulat U, Wettstein M, et al. Hyperosmolarity stimulates prostag landin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages[J]. Biochem J, 1995,312(Pt 1):135-143.
[78] Myers LK,Kang AH, Postlethwaite AE,et al. The genetic ablation of cyclooxygenase-2 prevents the development of autoimmune arthritis[J]. Arthritis Rheum,2000,43(12):2687-2693.
[80] Song Y G,Kwon H M, Kim J M,et al.Serologic and histopathologic study of chlamydia pneumoniae infection in atherosclerosis: a possible pathogenetic mechanism of atherosclerosis induced by chlamydia pneumoniae[J]. Yonsei Med J,2000,41(3):319-327.
[81] Speir E,Yu Z X, Ferrans V J,et al. Aspirin attenuates cytomegalovirus in ectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells[J]. Circ Res,1998,83(2):210-216.
[82] Tsujii M, Kawano S, DuBois RN, et al. Cyclooxygenase regulation angiogenesis induced by colon cancer cells[J]. Cell, 1998,93(5):705-716.
[83] N Kumahashi, M Ochi, Kataoka H, et al. Involvement of ATP, increase of intracellular calcium and the early expression of c-fos in the repair of rat fetal articular cartilage[J]. Cell Tissue Res 2004,317(2):117-28.
[84]邓凌霄,林建华.c-fos基因的表达与软骨的增殖及分化[J].中国临床康复.2006,10(l):138-141.
[85] Hassan Fahmi, DiBattista JA, Pelletier JP, et al. Peroxisome proliferatoractivated receptor gamma activators inhibit inter- leukin -lbeta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes[J]. Arthritis Rheum, 2001,44(3):595-607.
[1]娄思权.骨关节炎的病理与发病因素[J].中华骨科杂志,1996,16(1):56.
[2]娄玉钤.中国风湿病学(第1版)[M].北京:人民卫生出版社,2001,130-133.
[3]张如明.退变性膝骨关节病病因的实验观察和临床治疗的初步报告[J].中华骨科杂志,1994,14(10):612-614.
[4]张毓洲,许露玫,许振华,等.正常与骨内高压下骨髓微循环冷冻割断扫描电镜观察[J].中华骨科杂志,1999,19(5):303-306.
[5] Dey A.Effect of high tibialo osteotony on uppertibial venors drainage: Study by intraosseous phlebog-raphy in primary osteoarthritis of knee joint[J]. Ann Rheum Dis,1989,48:188-195.
[6]陈清汉,许振华,刘家勇,等.膝部疼痛与骨内压关系的临床研究[J].中华骨科杂志,1996,16(1):25-28.
[7] Rourne K S, I Ke RW. Diagnostic arthroscopy in the thearthritis patient[J]. Rheum D Clinics of North Am,1994,120:321-342.
[8]郑福增,程少丹.骨疏康治疗绝经后妇女膝关节功能障碍的疗效观察[J].中国临床康复,2004,8(17):3322-3323.
[9]阮祥燕,刘玉兰,彭舟丽,等.强骨胶囊对绝经后膝骨关节炎妇女膝关节有效活动度的影响[J].中国临床康复,2005,9(19):170-171.
[10]陈小凯,吴虹.巨刺治疗膝骨关节炎81例疗效观察[J].针灸临床杂志,2003,19(8):53.
[11]张颇,张闻生,邹季.风湿骨痛药酒药褪外治法治疗兔膝关节骨关节炎的实验研究[J].中医正骨,2001,13(7):9.
[12]舒强,李兴福,侯怀水,等.艾拉莫德对骨关节炎滑膜成纤维样细胞特性的影响.中华风湿病学杂志,2006,10(7):389-392.
[13] Benito MJ, Veale DJ, Fitz-Gerald O, et al. Synovial tissue inflammation in early and late osteoarthritis[J]. Ann Rheum Dis,2005,64:1263-1267.
[14]王巨,肖德明,李伟,5-氟脲嘧啶关节腔注射治疗兔膝骨关节炎的实验研究[J],中国矫形外科杂志,2006,9(17):1339-1341.
[15]董建勇,赵晓薇,李立.附桂关节汤防治骨关节炎作用形态学观察[J].甘肃中医学院学报,1997,14(1):27.
[16]许学猛,王羽丰,邓晋丰,等.补肾活血胶囊影响兔膝关节退变性疾病骨内压变化的实验研究[J].中国中医骨伤科杂志,2001,9(4):24.
[17]张德辉,薛刚,黄昌林.应用玻璃酸钠对关节镜术后膝骨关节炎功能恢复的影响[J].中国临床康复,2002,6(12):1730.
[18]龚权.细胞凋亡与骨关节炎研究进展[J].湖北省卫生职工医学院学报.2004,17(4):92-94.
[19] Hashimoto S,Setareh M,Roseen F,et al.Fas/Fas ligand expression and induction of apoptosis in chondrocytes[J]. Arthritis Rheum,1997,40 (10):1749.
[20] Pelletier JP,Fernandes JC,Jovanovic DV. Chondrocyte death in expertimental osteoarthritis is mediated by MEK1/2 and p38 pathways: role of cycle oxygenase-2 and inducible nitric oxide synthase[J]. J Rheumatol,2001,28 (11):2509.
[21] Heraud F,Heraud A,Harmand MF. Apoptosis in normal and osteoarthric human articular cartilage[J].Ann Rheum Dis,2000,59(12):9594.
[22] Hashimoto S,Ochs RL,Komiya S,Lotz M. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis[J]. Arthritis Rheum,1998,41 (9):1632.
[23] Miwa M,Saura R,Hirata S,et al. Induction of apoptosis in bovine articular chondrocyte by prostaglandin E(2) through cAMP-dependent pathway[J].Osteoarthritis Cartilage,2000,8(1):17.
[24] Kuhn K,Hashimoto S,Lotz M. Cell density modulates apoptosis in human articular chondrocytes[J].J Cell Physiol,1999,180 (3):439.
[25] Erlacher L,Maier R,Ullrich R,et al. Differential expression of the protooncogene bcl-2 in normal and steoarthritic human articular cartilage[J].J Rheumatol,1995,22 (5):926.
[26] Kim SJ,Hwang SG,Shin DY,et al. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NF-kappa B -dependent transcription and stabilization by serine 15 phosphory- lation[J].J Biol Chem,2002,277 (36):33501.
[27] Mukherjee P,Rachita C,Aisen PS,et al. Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death[J].Clin Exp Rheumatol,2001,19 (1):57.
[28] Pelletier JP,Jovanovic DV,Lascau-Coman V,et al. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo:possible link with there duction in chondrocyte apoptosis and caspase3 level[J].Arthritis Rheum,2000,43(6):1290.
[29] Cao L,Yang B. Chondrocyte apoptosis induced by aggree an G1 domain as a result of decreased cell adhesion[J].Exp Cell Res,1999,246(2):527.
[30]吕红斌,朱洁,胡建中,等.骨关节病滑膜细胞凋亡和癌基因的表达[J].中国运动医学杂志,1998,17 (4):296.
[31] Hacker G,Vaux DL. The medical significance of physiological cell death[J].Med Res Rev.1995,15:299-311.
[32] Susin SA,Zamzami N,Castedo M,et al. Bc1-2 inhibits the mitochondrial release of an apoptogenic protease[J]. J Exp Med 1996,184:1331-1341.
[33] Jovanovic DV,Mineau F,Notoya K,et al.Nitricoxide induced cell death inhuman osteoarthriticsynoviocytes is mediated by tyrosine kinase activation and hydrogen peroxide and/or superoxide formation[J]. J R heumatol,2002,29 (10):2165.
[34] Okamoto K,Kobayashi T,Kobata T,et al. Fas-associated death domain protein is a Fas-mediated apoptosis modulator in synoviocytes[J].Rheumatology (Oxford),2000,39 (5):471.
[35]蔡伟平,汤亭亭.骨关节炎的细胞生物学研究进展[J].国外医学·骨科学分册,2004,25(1),18-21.
[36] Pelletier JP,DiBattista JA,Routhley P,et al. Cytokines and inflammation in cartilage degradation[J]. Rheum Dis Clin North Am,1993,19:545-568.
[37]张洪斌.骨关节炎的基因治疗[J].中国临床康复,2003,7(32):4390-4391.
[38] Frnandes JC,Martel PJ,Pelletier JP. The role of cytokinesin osteoar thritis pathophysiology[J]. Biorheology,2002,39:237-246.
[39] Smith MD,Triantafillou S,Parker A,et al.Synovial membrane inflammation and cytokine production in patients with early osteoarthritis[J].J Rheumatol,1997,24:365-371.
[40] Pelletier JP,Caron JP,Evans CH,et al.Invivo suppression of early experimental osteoarthritis by interleukin 21 receptorant agonist usinggene therapy[J]. ArthritisRheum,1997,40:1020-1019.
[41] Arner EC,Harris RR,Dimeo TM,et al.Inter leukin21 receptor antagonist inhibits proteogly can break down inantigen induced but not polycation induce darthritis intherabbit[J]. J Rheumatol.1995,22:1338-1346.
[42] Makarov SS,Olsen JC,Johnston WN,et al.Suppression of experimental arthritis by gene tranfer of interleukin 21 receptor antagonistc DNA[J]. Proc Natl Acad Sci USA,1996,93:402-406.
[43] Hashimoto S,Takahashi K,Amiel D,et al.Chondrocy teapoptosis and nitric oxide production during experimentally induced osteoarthritis[J]. Arthritis Rheum,1998,41:1266-1274.
[44] Otani K,Nita I,MaCaulay W,et al.Suppression of antigen 2 induced arthritis by gene therapy[J]. J Immunol,1996,156:3558-3562.
[45]杨尚云,狄春辉,蒋明,等.白介素21受体拮抗剂基因治疗小鼠型胶原关节炎的疗效观察[J].中华医学杂志,2002,82:990-994.
[46] Yang GY, Di CH, Jiang M, et al. Effect of inter leukin 2 receptor antigonist gene therapy on arthritis induced by type collagenin mice[J]. Natl Med J China, 2002, 82:990-994.
[47] Evans CH, Ghivizzani SC, Kang R, et al. Genetherapy for rheumatic diseases[J]. Arthritis Rheum, 1999,42:1216.
[48] Smith GN Jr,Yu LP Jr,Brandt KD,et al . Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage[J]. J Rheumatol,1998,25(3:532-535.
[49] Billinghurst RC,Dahlberg L,Ionescu M,et al . Enhenced cleavage of typeⅡcollagenases in osteoarthritic cartilage[J].J Clin Invest. 1997,99(7):1534-1545.
[50]管剑龙,韩星海,施桂英,等.细胞因子和药物对软骨细胞和滑膜细胞金属蛋白酶活性的调节[J].第二军医大学学报,2000,11(9),861-864.
[51] Clegg PD,Burke RM,Coughlan AR,et al . Characterization of equine matrix Metalloproteinase 2 and 9,and identification of the cellular sources of these enzymes in joints[J]. Equine Vet J,1997,29(5):335-342.
[52] Takahashi S,Inoue T,Higaki M,et al . Cyclooxygenase inhibitors enhance the production of tissue inhibitor-1βof metalloproteinases( TIMP-1)and pro-matrix metalloproteinase-1(pro MMP-1)in human rheumatoid synovial fibroblasts [J]. Inflamm Res,1997,46(8):320-323.
[53]管剑龙,施桂英,韩星海,等.骨关节炎软骨细胞和滑膜细胞金属蛋白酶活性的影响因素[J].中华风湿病学杂志2001,5(1):19-22.
[54]邓凌霄,林建华.c-fos基因的表达与软骨的增殖及分化[J].中国临床康复,2006,10(l),138-141.
[55] S Riemer,S Gebhard, Beier F,et al. Role of c-fos in the regulation of type X collagen gene expression by PTH and PTHrP: localization of a PTH/P'PHrP-responsive region in the human enhancer[J].J Cell Biochem.2002,86(4): 688-699.
[56] TF Li,MJ Zuscik,Ionescu AMet al. PGE2 inhibits chondrocyte differ-entiation through PKA and PKC signaling[J]. Exp Cell Res 2004,300(1):159-169.
[57] N Kumahashi,M Ochi,Kataoka H,et al. Involvement of ATP,increase of intracellular calcium and the early expression of c-fos in the repair of rat fetal articular cartilage[J].Cell Tissue Res 2004,317(2):117-128.
[58] M Benderdour,G Tardif,Pelletier JP,et al. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1 beta[J].J Rheumatol. 2002,29(6):1262-1272.
[59] JB Catterall, S Carrere, Koshy PJ, et al.Synergistic induction of matrix metalloproteinase 1 by interleukin-lalpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism[J]. Arthritis Rheu. 2001,44(10): 296-310.
[60] Hassan Fahmi,DiBattista JA,Pelletier JP,et al. Peroxisome proliferator activated receptor gamma activators inhibit interleukin-lbeta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes[J].Arthritis Rheum 2001,44(3):595-607.
[61] Martin G,Andriamanalijaona R,Grassel S,et al.Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes[J]. Arthritis Rheu ,2004,50(11): 3549-60.
[62] MP Morgan,McC arthy GM. Signaling mechanisms involved in crystal-induced tissue damage[J].Curr Opin Rheumatol.2002,14(3):292-297.
[63] Morita I,Schindler M,Regier M K,et al.Different intracellular locations for prostaglandin endoperoxide H synthase-1 and 2[J].J Biol Chem,1995,270(18):10902-10908.
[64] Song Y G,Kwon H M,Kim J M,et al.Serologic and histopathologic study of chlamydia pneumoniae infection in atherosclerosis:a possible pathogenetic mechanism of atherosclerosis induced by chlamydia pneumoniae[J].Yonsei Med J,2000,41(3):319-327.
[65] Speir E,Yu Z X,Ferrans V J,et al.Aspirin attenuates cytomegalovirus in ectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells[J].Circ Res,1998,83(2):210-216.
[66] Stanford S J,Pepper J R,Mitchell J A.Cyclooxygenase-2 regulatesgranulocyte-macrophage colony-stimulating factor,but not interleukin-8,production by human vascular cells:role of cAMP[J].Arterioscler Thromb Vasc Biol,2000,20(3):677-682.